Frank Ruffo

Biography

Frank Ruffo co-founded Aclaris Therapeutics and has served as Chief Financial Officer since its inception in July 2012. He is a senior financial executive with more than 20 years of biotech and specialty pharmaceutical management expertise in early stage through fully commercial operations. From January 2014 to December 2015, Mr. Ruffo served part time as a financial consultant at Ralexar Therapeutics, Inc. (formerly known as Alexar Therapeutics, Inc.), a specialty dermatology company. Mr. Ruffo also served part time as the Chief Financial Officer of VenatoRx Pharmaceuticals Inc., a pharmaceutical company, from October 2011 to November 2014 and the Chief Financial Officer of BioLeap, Inc. from January 2010 to January 2013. Prior to joining Aclaris, Mr. Ruffo co-founded and served as Chief Financial Officer of Vicept Therapeutics, Inc. from 2009 until its acquisition by Allergan plc in July 2011. Prior to joining Vicept Therapeutics, Inc., from 1996 to 2008, he served as the Vice President, Finance and Controller of CollaGenex Pharmaceuticals, Inc. Mr. Ruffo is a certified public accountant in Pennsylvania (inactive since 2008). Mr. Ruffo received his Bachelor of Science in Accounting from La Salle University.

Research Interest

 Business & Mnagement.